A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD
This study has been completed.
Sponsor:
Abgenix
Information provided by:
Abgenix
ClinicalTrials.gov Identifier:
NCT00035828
First received: May 6, 2002
Last updated: June 23, 2005
Last verified: July 2003
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | December 2002 |
| Estimated Primary Completion Date: | No date given |